A nice editorial of where the controversy currently stands.
It fails to mention that the pro-screening findings of the Weill Cornell team is called into question by its acceptance of cigarette company money.
Related posts:
- PSA and prostate cancer screening
- CT scans and lung cancer screening
- The folly of lung cancer screening
- Lung cancer CT screening produces false positives and isn’t ready for prime time
- Will patients accept the limitations of prostate cancer screening?
- Should I get a PSA test for prostate cancer? A new study shows that screening for prostate cancer doesn’t necessarily save lives
- NEJM on Claudia Henschke
KevinMD.com on Facebook
 
Follow on Twitter  
Subscribe







{ 1 comment }
It’s very surprising that a respected science journalist of this caliber would ignore those details. The links at the bottom to past news stories on the subject of the industry support are not sufficient.
Comments on this entry are closed.